News and Trends 19 Sep 2022 Taiwan-based Anyong Biotechnology first to employ seafood stem-cell freezing …long time periods while preserving freshness in a previously impossible way with the traditional methods of freezing. Making sure to minimize waste, the company says it prevents degradation of quality… September 19, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Startup Scout 10 Nov 2022 ResQ Biotech is using bacteria to discover Alzheimer’s treatments …amyloid beta in the case of Alzheimer’s disease. The proteins are also engineered to fluoresce when they are correctly folded. If a peptide drug successfully prevents a protein from misfolding,… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 Stemline Therapeutics’ breast cancer treatment approved …data is consistent with the other endocrine therapies. Most of the adverse events (AEs), including nausea and musculoskeletal pain, were grade 1 and 2. No hematological safety signal was observed… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 16 Jul 2019 The Business of Biotech: What to Do When the S*#t Hits the Fan …a very long time, and their fate often depends on events where the probability of success is well below 50%. It’s a pressure cooker environment and whether the issue lies… July 16, 2019 - 5 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 2023 life sciences industry trends: adopting a digital-first mindset …monitor postmarket safety and adverse events (AE) to make regulatory decisions due to its increasing role in healthcare decisions. Many sources — like product and disease registries, claims and billing… January 11, 2023 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 Eye inflammation leads to FDA partial clinical hold on Nuvation Bio solid tumor study …said it proactively paused enrolment of new patients in order to further assess these adverse events with investigators and uveitis experts, and also reached out to the FDA for guidance… June 27, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2023 Med-Life Discoveries to start rare pediatric disease trial …disease that is caused by mutations in any one of several genes that prevents the biosynthesis of a critical class of phospholipids called plasmalogens. The lack of these lipids in… June 9, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? …become a model for pharmaceutical companies to be held accountable for jacking up drug prices in Europe. A new plan of action for AbbVie? In the wake of these events,… March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022 Aeglea BioTherapeutics updates homocystinuria program …role in multiple progressive and serious disease-related complications, including thromboembolic vascular events, skeletal abnormalities (including severe osteoporosis), developmental delay, intellectual disability, lens dislocation and severe near sightedness. In preclinical studies,… October 4, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023 Active Biotech trial confirms eye treatment safety …results, the eye drop was safe and well tolerated both at single ascending doses and after repeated doses for up to 21 days. No serious adverse events were reported. “There… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jun 2022 Study reveals progress for those with hepatitis B …treatment-related serious adverse events and two patients with mild, rapidly resolving transaminitis. Enhanced immune response VTP-300 is a novel immunotherapy, dosed in a prime-boost regimen, whereby the immune system is… June 24, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2022 Tetris Pharma launches hypoglycemia injector pen in Germany …launch of Ogluo means that patients living with diabetes in Germany who may experience severe hypoglycamia will now have a new option to tackle those events. We look forward to… November 1, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email